Direct-acting antivirals still underused in hep C-related liver cancer
Direct-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting, the annual meeting of the American ...
Nov 21, 2023
0
0